-
Je něco špatně v tomto záznamu ?
Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?
E. Krušinová, T. Pelikánová
Jazyk angličtina Země Irsko
Grantová podpora
NR8991
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- ateroskleróza metabolismus MeSH
- financování organizované MeSH
- lidé MeSH
- metabolický syndrom metabolismus MeSH
- proteiny vázající mastné kyseliny fyziologie metabolismus MeSH
- tuková tkáň metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
Adipocyte/macrophage fatty acid binding protein (A-FABP) has been shown to be closely associated with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has been recently suggested as a potential therapeutic target of these abnormalities in animal models. The present review aims to summarize current knowledge on A-FABP functions and regulations both in animal models and humans, since the role of A-FABP in human physiology and disease has not been presently clarified.
Citace poskytuje Crossref.org
- 000
- 01794naa 2200301 a 4500
- 001
- bmc11009970
- 003
- CZ-PrNML
- 005
- 20140303080230.0
- 008
- 110511s2008 ie e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.diabres.2008.09.023 $2 doi
- 035 __
- $a (PubMed)18977052
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Krušinová, Eva $7 xx0082037
- 245 10
- $a Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis? / $c E. Krušinová, T. Pelikánová
- 314 __
- $a Diabetes Centre, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 14021 Prague, Czech Republic.
- 520 9_
- $a Adipocyte/macrophage fatty acid binding protein (A-FABP) has been shown to be closely associated with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has been recently suggested as a potential therapeutic target of these abnormalities in animal models. The present review aims to summarize current knowledge on A-FABP functions and regulations both in animal models and humans, since the role of A-FABP in human physiology and disease has not been presently clarified.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a tuková tkáň $x metabolismus $7 D000273
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ateroskleróza $x metabolismus $7 D050197
- 650 _2
- $a proteiny vázající mastné kyseliny $x fyziologie $x metabolismus $7 D050556
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a metabolický syndrom $x metabolismus $7 D024821
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Pelikánová, Terezie, $d 1954- $7 jn20000807012
- 773 0_
- $t Diabetes Research & Clinical Practice $w MED00001385 $g Roč. 82,Suppl 2 (2008), s. S127-S134
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110513094854 $b ABA008
- 991 __
- $a 20140303080233 $b ABA008
- 999 __
- $a ok $b bmc $g 839241 $s 703377
- BAS __
- $a 3
- BMC __
- $a 2008 $b 82 $c Suppl 2 $d S127-S134 $m Diabetes research and clinical practice $n Diabetes Res Clin Pract $x MED00001385
- GRA __
- $a NR8991 $p MZ0
- LZP __
- $a 2011-2B09/jvme